These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23776363)

  • 21. "Other" breast cancer susceptibility genes: searching for more holy grail.
    Nathanson KL; Weber BL
    Hum Mol Genet; 2001 Apr; 10(7):715-20. PubMed ID: 11257104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
    Aloraifi F; McDevitt T; Martiniano R; McGreevy J; McLaughlin R; Egan CM; Cody N; Meany M; Kenny E; Green AJ; Bradley DG; Geraghty JG; Bracken AP
    FEBS J; 2015 Sep; 282(17):3424-37. PubMed ID: 26094658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia.
    Boujemaa M; Hamdi Y; Mejri N; Romdhane L; Ghedira K; Bouaziz H; El Benna H; Labidi S; Dallali H; Jaidane O; Ben Nasr S; Haddaoui A; Rahal K; Abdelhak S; Boussen H; Boubaker MS
    PLoS One; 2021; 16(1):e0245362. PubMed ID: 33503040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
    Anglian Breast Cancer Study Group
    Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.
    García MJ; Benítez J
    Clin Transl Oncol; 2008 Feb; 10(2):78-84. PubMed ID: 18258506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk.
    Solodskikh SA; Panevina AV; Gryaznova MV; Gureev AP; Serzhantova OV; Mikhailov AA; Maslov AY; Popov VN
    Mutat Res; 2019 Jan; 813():51-57. PubMed ID: 30611917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-Generation Sequencing Identifies
    Peker Eyüboğlu İ; Yenmiş G; Bingöl EN; Yüksel Ş; Tokat F; Özbek P; Güllü Amuran G; Yakıcıer C; Akkiprik M
    OMICS; 2020 Jan; 24(1):5-15. PubMed ID: 31851867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of
    Hamdi Y; Boujemaa M; Mighri N; Mejri N; Jaidane O; Ben Nasr S; Bouaziz H; Hassouna JB; Zribi A; Berrazaga Y; Rachdi H; Daoud N; El Benna H; Labidi S; Haddaoui A; Rahal K; Benna F; Boussen H; Abdelhak S; Boubaker S
    Front Genet; 2021; 12():674990. PubMed ID: 34456966
    [No Abstract]   [Full Text] [Related]  

  • 31. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial prostate cancer.
    Giri VN; Beebe-Dimmer JL
    Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspective: prostate cancer susceptibility genes.
    Simard J; Dumont M; Soucy P; Labrie F
    Endocrinology; 2002 Jun; 143(6):2029-40. PubMed ID: 12021166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Hughes DJ
    Fam Cancer; 2008; 7(3):233-44. PubMed ID: 18283561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
    Cline MS; Liao RG; Parsons MT; Paten B; Alquaddoomi F; Antoniou A; Baxter S; Brody L; Cook-Deegan R; Coffin A; Couch FJ; Craft B; Currie R; Dlott CC; Dolman L; den Dunnen JT; Dyke SOM; Domchek SM; Easton D; Fischmann Z; Foulkes WD; Garber J; Goldgar D; Goldman MJ; Goodhand P; Harrison S; Haussler D; Kato K; Knoppers B; Markello C; Nussbaum R; Offit K; Plon SE; Rashbass J; Rehm HL; Robson M; Rubinstein WS; Stoppa-Lyonnet D; Tavtigian S; Thorogood A; Zhang C; Zimmermann M; ; Burn J; Chanock S; Rätsch G; Spurdle AB
    PLoS Genet; 2018 Dec; 14(12):e1007752. PubMed ID: 30586411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
    Wendt C; Margolin S
    Acta Oncol; 2019 Feb; 58(2):135-146. PubMed ID: 30606073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.